Yu, H., Sun, X., Li, Y., Pan, J., Liu, X., He, H., Wu, H., Sun, Y., Pan, Y., Qian, X.

Background
Despite the clinical efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in non-small cell lung cancer (NSCLC), patient outcomes vary even among those with identical EGFR mutations. This study investigates wh…